Perimeter Solutions Group Partners with Strategic Fence & Wall
Expands Integrated Perimeter Protection Platform to
"We are proud to partner with Jack to expand PSG's capabilities into
The transaction represents PSG's seventh acquisition since 2021 and the second since Bertram and PSG announced their partnership in
"Strategic Fence is proud to be joining the PSG team and its national platform providing commercial fence, gate and automation solutions," said
PSG is focused on bringing together the nation's highest-quality commercial fence, temporary fence, gate fabrication, and access control brands. PSG is seeking partnership opportunities that help broaden geographic reach and/or capabilities. Acquisition opportunities may be directed to
About Perimeter Solutions Group
PSG operates six core locations and provides permanent and rental fencing, gate and access control solutions to customers across the US. The company is trusted by its customers as the preferred national provider of advanced perimeter security solutions for a diverse range of projects, sites and end markets. The company serves developers, owners and managers of multi-family, industrial, office, retail, stadiums, parks, medical, data center and renewable energy sites. For more information, please visit the company's website: https://perimetersolutionsgroup.com/.
About Strategic Fence
Strategic Fence is a leading permanent fence and gate installation business in
About Bertram Capital
Bertram Capital is a private equity firm targeting investments in lower middle market companies. Since its inception in 2006, the firm has raised over
CONTACT:
David Hellier
[email protected]
650-358-5000
View original content to download multimedia:https://www.prnewswire.com/news-releases/perimeter-solutions-group-partners-with-strategic-fence--wall-302384331.html
SOURCE Bertram Capital
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XRP Healthcare, the First AI Healthcare Platform Built on the XRP Ledger, Announces BitMart Listing of XRPHAI
- ALZHEIMER'S BLOOD TEST COULD BRING HIGHLY ACCURATE DIAGNOSIS INTO EVERYDAY CLINICAL CARE
- FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share